1. |
Lu TF, Yang TH, Zhong CP, <italic>et al</italic>. Dual effect of hepatic macrophages on liver ischemia and reperfusion injury during liver transplantation. Immune Netw, 2018, 18(3): e24.
|
2. |
Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol, 2017, 17(5): 306-321.
|
3. |
Bonnardel J, T'Jonck W, Gaublomme D, <italic>et al</italic>. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage. Immunity, 2019, 51(4): 638-654.e9.
|
4. |
Vago JP, Galvão I, Negreiros-Lima JL, <italic>et al</italic>. Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance. Pharmacol Res, 2020, 159: 104842.
|
5. |
Mardani F, Seifi B, Mohammadi A, <italic>et al</italic>. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol, 2018, 233(9): 6425-6440.
|
6. |
Jones AE, Divakaruni AS. Macrophage activation as an archetype of mitochondrial repurposing. Mol Aspects Med, 2020, 71: 100838.
|
7. |
Oliveira THC, Marques PE, Proost P, <italic>et al</italic>. Neutrophils: a cornerstone of liver ischemia and reperfusion injury. Lab Invest, 2018, 98(1): 51-62.
|
8. |
Mihm S. Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver. Int J Mol Sci, 2018, 19(10): 3104.
|
9. |
Ni DL, Wei H, Chen WY, <italic>et al</italic>. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: The perfect imperfection. Adv Mater, 2019, 31(40): e1902956.
|
10. |
Kahn J, Schemmer P. Control of ischemia-reperfusion injury in liver transplantation: potentials for increasing the donor pool. Visc Med, 2018, 34(6): 444-448.
|
11. |
Zheng DF, Li ZT, Wei XF, <italic>et al</italic>. Role of miR-148a in mitigating hepatic ischemia-reperfusion injury by repressing the TLR4 signaling pathway <italic>via</italic> targeting CaMKⅡα <italic>in vivo</italic> and <italic>in vitro</italic>. Cell Physiol Biochem, 2018, 49(5): 2060-2072.
|
12. |
Cheng MX, Huang P, He Q, <italic>et al</italic>. Liver X receptors activation attenuates ischemia reperfusion injury of liver graft in rats. J Invest Surg, 2019, 32(4): 298-303.
|
13. |
刘文平, 张永川, 张映林. 丹参酮ⅡA 在小鼠肝脏缺血再灌注损伤模型中的保护作用及机制. 中国普外基础与临床杂志, 2020, 27(3): 298-303.
|
14. |
Khambu B, Yan S, Huda N, <italic>et al</italic>. Role of high-mobility group box-1 in liver pathogenesis. Int J Mol Sci, 2019, 20(21): 5314.
|
15. |
Lai X, Gong JH, Wang WM, <italic>et al</italic>. Acetyl-3-aminoethyl salicylate ameliorates hepatic ischemia/reperfusion injury and liver graft survival through a high-mobility group box 1/toll-like receptor 4-dependent mechanism. Liver Transpl, 2019, 25(8): 1220-1232.
|
16. |
Wen SH, Li X, Ling YH, <italic>et al</italic>. HMGB1-associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats. FASEB J, 2020, 34(3): 4384-4402.
|
17. |
Zhao GY, Fu C, Wang L, <italic>et al</italic>. Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury. Sci Rep, 2017, 7: 46272.
|
18. |
Cochet F, Peri F. The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) signalling. Int J Mol Sci, 2017, 18(11): 2318.
|
19. |
Kopp F, Kupsch S, Schromm AB. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of lbp in intracellular LPS-signaling. Biochim Biophys Acta, 2016, 1863(4): 660-672.
|
20. |
Bai H, Wen J, Gong JP, <italic>et al</italic>. Blockade of the Notch1/Jagged1 pathway in Kupffer cells aggravates ischemia-reperfusion injury of orthotopic liver transplantation in mice. Autoimmunity, 2019, 52(4): 176-184.
|
21. |
Li J, Ke WB, Zhou Q, <italic>et al</italic>. Tumour necrosis factor-α promotes liver ischaemia-reperfusion injury through the PGC-1α/Mfn2 pathway. J Cell Mol Med, 2014, 18(9): 1863-1873.
|
22. |
Su L, Li N, Tang H, <italic>et al</italic>. Kupffer cell-derived TNF-α promotes hepatocytes to produce CXCL1 and mobilize neutrophils in response to necrotic cells. Cell Death Dis, 2018, 9(3): 323.
|
23. |
Al-Saeedi M, Liang R, Schultze DP, <italic>et al</italic>. Glycine protects partial liver grafts from Kupffer cell-dependent ischemia-reperfusion injury without negative effect on regeneration. Amino Acids, 2019, 51(6): 903-911.
|
24. |
Yue S, Zhu JJ, Zhang M, <italic>et al</italic>. The myeloid heat shock transcription factor 1/β-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury. Hepatology, 2016, 64(5): 1683-1698.
|
25. |
Jin YT, Li CY, Xu DW, et al. Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cell Mol Immunol, 2019 Oct 31. doi: 10.1038/s41423-019-0318-x.
|
26. |
Chen N, Ou ZB, Zhang WF, <italic>et al</italic>. Cathepsin B regulates non-canonical NLRP3 inflammasome pathway by modulating activation of caspase-11 in Kupffer cells. Cell Prolif, 2018, 51(6): e12487.
|
27. |
Cheng MX, Cao D, Chen Y, <italic>et al</italic>. α-ketoglutarate attenuates ischemia-reperfusion injury of liver graft in rats. Biomed Pharmacother, 2019, 111: 1141-1146.
|
28. |
Roth K, Rockwell CE, Copple BL. Differential sensitivity of Kupffer cells and hepatic monocyte-derived macrophages to bacterial lipopolysaccharide. Clin Exp Gastroenterol Hepatol, 2019, 1(1): 106.
|
29. |
Kageyama S, Hirao H, Nakamura K, et al. Recipient HO-1 inducibility is essential for posttransplant hepatic HO-1 expression and graft protection: From bench-to-bedside. Am J Transplant, 2019, 19(2): 356-367.
|
30. |
Xu DW, Chen LL, Chen XS, <italic>et al</italic>. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy. Cell Death Dis, 2017, 8(8): e2983.
|
31. |
Zhang M, Nakamura K, Kageyama S, <italic>et al</italic>. Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury. JCI Insight, 2018, 3(19): e120596.
|
32. |
Hirao H, Dery KJ, Kageyama S, Net al. Heme oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside. Free Radic Biol Med, 2020: S0891-5849(19)31510-2.
|
33. |
Rao J, Cheng F, Yang S, <italic>et al</italic>. Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury. Cell Mol Immunol, 2019, 16(1): 98-100.
|
34. |
Li P, He K, Li J, <italic>et al</italic>. The role of Kupffer cells in hepatic diseases. Mol Immunol, 2017, 85: 222-229.
|
35. |
Wu H, Xu X, Li J, <italic>et al</italic>. TIM-4 blockade of KCs combined with exogenous TGF-β injection helps to reverse acute rejection and prolong the survival rate of mice receiving liver allografts. Int J Mol Med, 2018, 42(1): 346-358.
|
36. |
Li Y, Ma D, Wang Z, <italic>et al</italic>. MicroRNA-155 deficiency in Kupffer cells ameliorates liver ischemia-reperfusion injury in mice. Transplantation, 2017, 101(7): 1600-1608.
|